Roivant Sciences LtdEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 35.01 USD | 37 USD | 10,9 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 38,35 USD | 6 | 3 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 719.270.385 | 6,73 | 5,83 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Roivant Sciences Ltd
Mitarbeiter 721
Handelsplatz NASDAQ
Ticker Symbol ROIV
IPO Datum 2021-10-01
Adresse 50 Broadway, London, United Kingdom, SW1H 0DB
Webseite https://roivant.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Matthew Gline | CEO & Director |
| 2 | Dr. Eric Venker M.D., Pharm.D. | President & CEO of Immunovant |
| 3 | Dr. Mayukh Sukhatme M.D. | President, Chief Investment Officer & Director |
| 4 | Mr. Richard Pulik | Chief Financial Officer |
| 5 | Ms. Jennifer Humes | Chief Accounting Officer |
| 6 | Dr. Frank M. Torti M.B.A., M.D. | President & Vant Chair |
| 7 | Dr. Huafeng Xu Ph.D. | Chief Technology Officer |
| 8 | Mr. Ian Rosenblum | Chief Information Officer |
| 9 | Ms. Kelly Graff | Head of People |
| 10 | Mr. Alex Gasner | Executive Vice President of Roivant Health |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 2 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 3 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | Qvt Financial LP | 0,00% | 0,00 Mio. USD |
| 6 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 10 | Adage Capital Partners Gp LLC | 0,00% | 0,00 Mio. USD |
| 11 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 12 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Farallon Capital Management, L.L.C. | 0,00% | 0,00 Mio. USD |
| 14 | Two Seas Capital LP | 0,00% | 0,00 Mio. USD |
| 15 | Assenagon Asset Management SA | 0,00% | 0,00 Mio. USD |
| 16 | Perceptive Advisors LLC | 0,00% | 0,00 Mio. USD |
| 17 | Patient Square Capital LP | 0,00% | 0,00 Mio. USD |
| 18 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 19 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 20 | Darwin Global Management, Ltd. | 0,00% | 0,00 Mio. USD |